IL10 and neoplasm: IL-10, possessing immunomodulatory properties, requires comprehensive evaluation of both malignant and immune cell activities for proper interpretation; its reduction suggests waning immunosuppression (potentially indicating impaired host immunity) while paradoxically possibly reflecting amelioration of tumor-associated chronic inflammation.